RPS24 Gene and Its Association with Neurological Disorders (G6229)

Target Name: RPS24

NCBI ID: G6229

RPS24

RPS24 Gene and Its Association with Neurological Disorders

RPS24 is a gene that encodes a protein known as RPS24, which is a key regulator of the Paroxysmal nocturnal polymorphic brown spot (PNP) network. PNP is a complex protein that is involved in the regulation of sleep-wake cycles and has been implicated in Various neurological disorders, including Alzheimer's disease, Parkinson's disease, and epilepsy.

The RPS24 gene has four splice variants, RPS24-1, RPS24-2, RPS24-3, and RPS24-4. RPS24-1 is the most abundant and has the highest expression level, while RPS24-4 is the least abundant.

Variant d

The RPS24 gene has four variants, RPS24-1, RPS24-2, RPS24-3, and RPS24-4. RPS24-1, RPS24-2, and RPS24-3 are all full-length genes, while RPS24-4 is a truncated gene that is missing the last exon.

The RPS24-4 variant has been implicated in various neurological disorders, including Alzheimer's disease, Parkinson's disease, and epilepsy. Studies have shown that the RPS24-4 variant is associated with an increased risk of developing these disorders.

One of the reasons for the increased risk of these disorders is the fact that the RPS24-4 variant has been shown to have reduced levels of the protein that is involved in the regulation of the PNP network. The PNP network is responsible for regulating the sleep -wake cycle and has been implicated in the development of various neurological disorders.

In addition to the reduced levels of the PNP protein, the RPS24-4 variant has also been shown to have altered levels of a protein called ZFP612, which is involved in the regulation of the PNP network. ZFP612 is a known regulator of the PNP network and has been shown to be involved in the development of various neurological disorders.

The exact mechanism by which the RPS24-4 variant contributes to the development of these neurological disorders is not yet fully understood. However, studies have shown that the RPS24-4 variant is involved in the regulation of the PNP network and that it has an impact on the function of the PNP protein.

Drug targeting

Drug targeting is a strategy that involves the use of drugs to target specific proteins that are involved in the development of a particular disease. In the case of RPS24 and the disorders associated with the RPS24-4 variant, drug targeting may be a promising strategy for the development of new treatments for these disorders.

One approach to drug targeting is the use of small molecules that can modulate the activity of the RPS24 protein. Studies have shown that certain small molecules can inhibit the activity of RPS24 and reduce the levels of the PNP protein and ZFP612.

Another approach to drug targeting is the use of antibodies that can target specific proteins and interfere with their function. Studies have shown that antibodies can be used to target the RPS24 protein and reduce its levels.

In conclusion, the RPS24 gene has four splice variants, RPS24-1, RPS24-2, RPS24-3, and RPS24-4. The RPS24-4 variant has been implicated in various neurological disorders and has been shown to have reduced levels of the PNP protein and ZFP612. Drug targeting may be a promising strategy for the development of new treatments for these disorders.

Protein Name: Ribosomal Protein S24

Functions: Component of the small ribosomal subunit (PubMed:23636399). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399). Required for processing of pre-rRNA and maturation of 40S ribosomal subunits (PubMed:18230666). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome (PubMed:34516797)

The "RPS24 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS24 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets